{
    "id": 46,
    "premise": "none",
    "hypothesis": "Patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA.",
    "label": "entailment",
    "explanation": "PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA.\nSynthetic lethality is when co-occurrence of multiple genetic events results in cell death.",
    "results": {
        "semantic validity": false,
        "premise": null,
        "hypothesis": "Patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA.",
        "history explanation": [
            "0 iteration: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA.\nSynthetic lethality is when co-occurrence of multiple genetic events results in cell death.",
            "1 iteration: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA.\nSynthetic lethality is when co-occurrence of multiple genetic events results in cell death.",
            "2 iteration: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA.\nSynthetic lethality is when co-occurrence of multiple genetic events results in cell death.",
            "3 iteration: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA.\nSynthetic lethality is when co-occurrence of multiple genetic events results in cell death.",
            "4 iteration: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error-prone NHEJ to repair DNA.\nSynthetic lethality occurs when the co-occurrence of multiple genetic events, such as the loss of PALB2, results in cell death due to the reliance on a singular mechanism to repair cumulative DNA damage.\nThe loss of PALB2 in cells can lead to synthetic lethality when combined with PARP1 inhibition, as it forces cells to depend on a singular, often inadequate, DNA repair mechanism, leading to cell death.",
            "5 iteration: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error-prone NHEJ to repair DNA.\nSynthetic lethality occurs when the co-occurrence of multiple genetic events, such as the loss of PALB2, results in cell death due to the reliance on a singular mechanism to repair cumulative DNA damage.\nThe loss of PALB2 in cells can lead to synthetic lethality when combined with PARP1 inhibition, as it forces cells to depend on a singular, often inadequate, DNA repair mechanism, leading to cell death.",
            "6 iteration: PARP inhibitors cause replication\u2010associated double-strand breaks by preventing single-strand break repair, which forces cells to rely on defective homologous recombination repair and error-prone non-homologous end joining to repair DNA.\nSynthetic lethality occurs when the co-occurrence of multiple genetic events, such as the loss of PALB2, results in cell death due to the reliance on a singular mechanism to repair cumulative DNA damage.\nThe loss of PALB2 in cells can lead to synthetic lethality when combined with PARP1 inhibition, as it forces cells to depend on a singular, often inadequate, DNA repair mechanism, leading to cell death.\nWhen cells with a loss of PALB2 rely on a singular DNA repair mechanism due to PARP1 inhibition, this can create a therapeutic window where patients may benefit from the treatment, as the inadequate repair mechanism leads to cell death.",
            "7 iteration: PARP inhibitors cause replication\u2010associated double-strand breaks by preventing single-strand break repair, which forces cells to rely on defective homologous recombination repair and error-prone non-homologous end joining to repair DNA.\nSynthetic lethality occurs when the co-occurrence of multiple genetic events, such as the loss of PALB2, results in cell death due to the reliance on a singular mechanism to repair cumulative DNA damage.\nThe loss of PALB2 in cells can lead to synthetic lethality when combined with PARP1 inhibition, as it forces cells to depend on a singular, often inadequate, DNA repair mechanism, leading to cell death.\nWhen cells with a loss of PALB2 rely on a singular DNA repair mechanism due to PARP1 inhibition, this can create a therapeutic window where patients may benefit from the treatment, as the inadequate repair mechanism leads to cell death.",
            "8 iteration: PARP inhibitors cause replication\u2010associated double-strand breaks by preventing single-strand break repair, which forces cells to rely on defective homologous recombination repair and error-prone non-homologous end joining to repair DNA.\nSynthetic lethality occurs when the co-occurrence of multiple genetic events, such as the loss of PALB2, results in cell death due to the reliance on a singular mechanism to repair cumulative DNA damage.\nThe loss of PALB2 in cells can lead to synthetic lethality when combined with PARP1 inhibition, as it forces cells to depend on a singular, often inadequate, DNA repair mechanism, leading to cell death.\nWhen cells with a loss of PALB2 rely on a singular DNA repair mechanism due to PARP1 inhibition, this can create a therapeutic window where patients may benefit from the treatment, as the inadequate repair mechanism leads to cell death.",
            "9 iteration: PARP inhibitors cause replication\u2010associated double-strand breaks by preventing single-strand break repair, which forces cells to rely on defective homologous recombination repair and error-prone non-homologous end joining to repair DNA.\nSynthetic lethality occurs when the co-occurrence of multiple genetic events, such as the loss of PALB2, results in cell death due to the reliance on a singular mechanism to repair cumulative DNA damage.\nThe loss of PALB2 in cells, when combined with PARP1 inhibition, directly leads to reliance on a singular, often inadequate, DNA repair mechanism, resulting in synthetic lethality and cell death.\nWhen cells with a loss of PALB2 rely on a singular DNA repair mechanism due to PARP1 inhibition, this can create a therapeutic window where patients may benefit from the treatment, as the inadequate repair mechanism leads to cell death.",
            "10 iteration: PARP inhibitors cause replication\u2010associated double-strand breaks by preventing single-strand break repair, which forces cells to rely on defective homologous recombination repair and error-prone non-homologous end joining to repair DNA.\nSynthetic lethality occurs when the co-occurrence of multiple genetic events, such as the loss of PALB2, results in cell death due to the reliance on a singular mechanism to repair cumulative DNA damage.\nThe loss of PALB2 in cells, when combined with PARP1 inhibition, directly leads to reliance on a singular, often inadequate, DNA repair mechanism, resulting in synthetic lethality and cell death.\nWhen cells with a loss of PALB2 rely on a singular DNA repair mechanism due to PARP1 inhibition, this can create a therapeutic window where patients may benefit from the treatment, as the inadequate repair mechanism leads to cell death."
        ],
        "history semantic validity": [
            "0 iteration: False",
            "1 iteration: False",
            "2 iteration: False",
            "3 iteration: False",
            "4 iteration: False",
            "5 iteration: False",
            "6 iteration: False",
            "7 iteration: False",
            "8 iteration: False",
            "9 iteration: False",
            "10 iteration: False"
        ],
        "history critique output": [
            "0 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 8.212395191192627, 'proof tactics': ['Type unification failed: Clash of types \"_ \\\\<Rightarrow> _\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  Patient e4 :: entity \\\\<Rightarrow> bool\\nOperand:   DNA :: entity \\\\<Rightarrow> bool\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_46_0\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  PARPInhibitors :: \"entity \u21d2 bool\"\\n  DSBs :: \"entity \u21d2 bool\"\\n  SSBreakRepair :: \"entity \u21d2 bool\"\\n  HRR :: \"entity \u21d2 bool\"\\n  NHEJ :: \"entity \u21d2 bool\"\\n  DNA :: \"entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  Rely :: \"event \u21d2 bool\"\\n  Repair :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Means :: \"event \u21d2 entity \u21d2 bool\"\\n  SyntheticLethality :: \"entity \u21d2 bool\"\\n  GeneticEvents :: \"entity \u21d2 bool\"\\n  CellDeath :: \"entity \u21d2 bool\"\\n  CoOccurrence :: \"event \u21d2 bool\"\\n  Result :: \"event \u21d2 entity \u21d2 bool\"\\n  Patients :: \"entity \u21d2 bool\"\\n  LossOfPALB2 :: \"entity \u21d2 bool\"\\n  PARP1Inhibition :: \"entity \u21d2 bool\"\\n  Benefit :: \"event \u21d2 bool\"\\n  Mechanism :: \"event \u21d2 bool\"\\n  \\n(* Explanation 1: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w v u e1 e2 e3 e4. PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z \u2227 HRR w \u2227 NHEJ v \u2227 DNA u \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Rely e3 \u2227 Agent e3 x \u2227 Means e3 w \u2227 Means e3 v \u2227 Repair e4 \u2227 Agent e4 x \u2227 Patient e4 u\"\\n\\n(* Explanation 2: Synthetic lethality is when co-occurrence of multiple genetic events results in cell death. *)\\naxiomatization where\\n  explanation_2: \"\u2200x y z e. SyntheticLethality x \u2227 GeneticEvents y \u2227 CellDeath z \u27f6 (CoOccurrence e \u2227 Agent e y \u2227 Result e z)\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Patients x \u2227 LossOfPALB2 x \u2227 PARP1Inhibition y \u2227 SyntheticLethality z \u2227 Cells w\"\\n  (* Hypothesis: Patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA. *)\\n  shows \"\u2203x y z w e1 e2 e3 e4. Patients x \u2227 LossOfPALB2 x \u2227 PARP1Inhibition y \u2227 SyntheticLethality z \u2227 Cells w \u2227 Benefit e1 \u2227 Agent e1 x \u2227 Source e1 y \u2227 Cause e2 \u2227 Agent e2 z \u2227 Patient e2 w \u2227 Rely e3 \u2227 Agent e3 w \u2227 Mechanism e3 \u2227 Repair e4 \u2227 Agent e4 w \u2227 Patient e4 DNA\"\\nproof -\\n  (* From the premise, we have known information about patients, loss of PALB2, PARP1 inhibition, synthetic lethality, and cells. *)\\n  from asm have \"Patients x \u2227 LossOfPALB2 x \u2227 PARP1Inhibition y \u2227 SyntheticLethality z \u2227 Cells w\" <ATP>\\n  (* Explanation 2 provides a logical relation: Equivalent(E, And(F, G)), which means synthetic lethality is equivalent to the co-occurrence of multiple genetic events resulting in cell death. *)\\n  (* From the known information, we have SyntheticLethality z, which implies the co-occurrence of multiple genetic events and results in cell death. *)\\n  then have \"CoOccurrence e \u2227 Agent e GeneticEvents \u2227 Result e CellDeath\" <ATP>\\n  (* From the derived implications, we have Implies(E, G), which means synthetic lethality implies results in cell death. *)\\n  then have \"CellDeath\" <ATP>\\n  (* The hypothesis states that patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA. *)\\n  (* We need to show that there exists a benefit from PARP1 inhibition, which is related to the synthetic lethality causing cells to rely on a singular mechanism to repair DNA. *)\\n  (* From the logical relations, we have Implies(E, G) and Implies(E, F), which means synthetic lethality implies results in cell death and co-occurrence of multiple genetic events. *)\\n  (* Therefore, we can infer that the synthetic lethality causes cells to rely on a singular mechanism to repair cumulative damage to DNA. *)\\n  then have \"Benefit e1 \u2227 Agent e1 x \u2227 Source e1 y \u2227 Cause e2 \u2227 Agent e2 z \u2227 Patient e2 w \u2227 Rely e3 \u2227 Agent e3 w \u2227 Mechanism e3 \u2227 Repair e4 \u2227 Agent e4 w \u2227 Patient e4 DNA\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: PARP inhibitors cause replication\u2010associated DSBs (from Explanatory Sentence 1)\\nB: preventing SS break repair (from Explanatory Sentence 1)\\nC: relying on defective HRR (from Explanatory Sentence 1)\\nD: relying on error prone NHEJ to repair DNA (from Explanatory Sentence 1)\\nE: synthetic lethality (from Explanatory Sentence 2)\\nF: co-occurrence of multiple genetic events (from Explanatory Sentence 2)\\nG: results in cell death (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, And(B, Or(C, D)))\\nImplies(PARP inhibitors cause replication\u2010associated DSBs, B & (C | D))\\n--------\\nEquivalent(E, And(F, G))\\nEquivalent(synthetic lethality, F & G)\\n--------\\n\\nDerived Implications:\\nImplies(Not(G), Not(E))\\nImplies(Not(results in cell death), Not(synthetic lethality))\\n--------\\nImplies(Not(F), Not(E))\\nImplies(Not(co-occurrence of multiple genetic events), Not(synthetic lethality))\\n--------\\nImplies(E, G)\\nImplies(synthetic lethality, results in cell death)\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(preventing SS break repair), Not(PARP inhibitors cause replication\u2010associated DSBs))\\n--------\\nImplies(A, B)\\nImplies(PARP inhibitors cause replication\u2010associated DSBs, preventing SS break repair)\\n--------\\nImplies(E, F)\\nImplies(synthetic lethality, co-occurrence of multiple genetic events)\\n--------\\n'}",
            "1 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 9.768902063369751, 'proof tactics': ['Type unification failed: Clash of types \"event\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  Agent e3 :: entity \\\\<Rightarrow> bool\\nOperand:   e2 :: event\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_46_1\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  PARPInhibitors :: \"entity \u21d2 bool\"\\n  DSBs :: \"entity \u21d2 bool\"\\n  SSBreakRepair :: \"entity \u21d2 bool\"\\n  HRR :: \"event \u21d2 bool\"\\n  NHEJ :: \"event \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  Rely :: \"event \u21d2 bool\"\\n  Defective :: \"event \u21d2 bool\"\\n  Repair :: \"event \u21d2 bool\"\\n  DNA :: \"event \u21d2 bool\"\\n  ErrorProne :: \"event \u21d2 bool\"\\n  SyntheticLethality :: \"entity \u21d2 bool\"\\n  GeneticEvents :: \"entity \u21d2 bool\"\\n  CellDeath :: \"entity \u21d2 bool\"\\n  CoOccurrence :: \"event \u21d2 bool\"\\n  Result :: \"event \u21d2 bool\"\\n  Patients :: \"entity \u21d2 bool\"\\n  LossOfPALB2 :: \"entity \u21d2 bool\"\\n  PARP1Inhibition :: \"entity \u21d2 bool\"\\n  Benefit :: \"event \u21d2 bool\"\\n  Cells :: \"event \u21d2 bool\"\\n  Mechanism :: \"event \u21d2 bool\"\\n  Damage :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e1 e2 e3 e4. PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z \u2227 HRR e3 \u2227 NHEJ e4 \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Rely e3 \u2227 Agent e3 x \u2227 Defective e3 \u2227 Repair e3 \u2227 DNA e3 \u2227 ErrorProne e4 \u2227 Repair e4 \u2227 DNA e4\"\\n\\n(* Explanation 2: Synthetic lethality is when co-occurrence of multiple genetic events results in cell death. *)\\naxiomatization where\\n  explanation_2: \"\u2200x y z e1 e2. SyntheticLethality x \u2227 GeneticEvents y \u2227 CellDeath z \u2227 CoOccurrence e1 \u2227 Agent e1 y \u2227 Result e2 \u2227 Agent e2 y \u2227 Patient e2 z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Patients x \u2227 LossOfPALB2 x \u2227 PARP1Inhibition y \u2227 SyntheticLethality z\"\\n  (* Hypothesis: Patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA. *)\\n  shows \"\u2203x y z e1 e2 e3. Patients x \u2227 LossOfPALB2 x \u2227 PARP1Inhibition y \u2227 SyntheticLethality z \u2227 Benefit e1 \u2227 Agent e1 x \u2227 Source e1 y \u2227 Cause e2 \u2227 Agent e2 z \u2227 Cells e3 \u2227 Rely e3 \u2227 Agent e3 e2 \u2227 Mechanism e3 \u2227 Repair e3 \u2227 Damage e3 \u2227 DNA e3\"\\nproof -\\n  (* From the premise, we have known information about patients, loss of PALB2, PARP1 inhibition, and synthetic lethality. *)\\n  from asm have \"Patients x \u2227 LossOfPALB2 x \u2227 PARP1Inhibition y \u2227 SyntheticLethality z\" <ATP>\\n  (* We know from explanation 2 that synthetic lethality is equivalent to the co-occurrence of multiple genetic events resulting in cell death. *)\\n  (* This implies that synthetic lethality causes cell death, which is a key part of the hypothesis. *)\\n  from explanation_2 have \"SyntheticLethality z \u27f6 (CoOccurrence e1 \u2227 CellDeath e2)\" <ATP>\\n  (* Since we have SyntheticLethality z, we can infer CoOccurrence e1 and CellDeath e2. *)\\n  then have \"CoOccurrence e1 \u2227 CellDeath e2\" <ATP>\\n  (* The hypothesis involves the benefit of PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA. *)\\n  (* We can use the derived implication that synthetic lethality implies cell death, and this can be linked to the benefit of PARP1 inhibition. *)\\n  then have \"Benefit e1 \u2227 Agent e1 x \u2227 Source e1 y \u2227 Cause e2 \u2227 Agent e2 z \u2227 Cells e3 \u2227 Rely e3 \u2227 Agent e3 e2 \u2227 Mechanism e3 \u2227 Repair e3 \u2227 Damage e3 \u2227 DNA e3\" <ATP>\\n  (* Therefore, we can conclude the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: PARP inhibitors cause replication\u2010associated DSBs (from Explanatory Sentence 1)\\nB: preventing SS break repair (from Explanatory Sentence 1)\\nC: relying on defective HRR (from Explanatory Sentence 1)\\nD: relying on error prone NHEJ to repair DNA (from Explanatory Sentence 1)\\nE: synthetic lethality (from Explanatory Sentence 2)\\nF: co-occurrence of multiple genetic events (from Explanatory Sentence 2)\\nG: cell death (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, And(B, C, D))\\nImplies(PARP inhibitors cause replication\u2010associated DSBs, B & C & D)\\n--------\\nEquivalent(E, And(F, G))\\nEquivalent(synthetic lethality, F & G)\\n--------\\n\\nDerived Implications:\\nImplies(Not(D), Not(A))\\nImplies(Not(relying on error prone NHEJ to repair DNA), Not(PARP inhibitors cause replication\u2010associated DSBs))\\n--------\\nImplies(Not(G), Not(E))\\nImplies(Not(cell death), Not(synthetic lethality))\\n--------\\nImplies(A, C)\\nImplies(PARP inhibitors cause replication\u2010associated DSBs, relying on defective HRR)\\n--------\\nImplies(Not(F), Not(E))\\nImplies(Not(co-occurrence of multiple genetic events), Not(synthetic lethality))\\n--------\\nImplies(E, G)\\nImplies(synthetic lethality, cell death)\\n--------\\nImplies(A, B)\\nImplies(PARP inhibitors cause replication\u2010associated DSBs, preventing SS break repair)\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(preventing SS break repair), Not(PARP inhibitors cause replication\u2010associated DSBs))\\n--------\\nImplies(A, D)\\nImplies(PARP inhibitors cause replication\u2010associated DSBs, relying on error prone NHEJ to repair DNA)\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(relying on defective HRR), Not(PARP inhibitors cause replication\u2010associated DSBs))\\n--------\\nImplies(E, F)\\nImplies(synthetic lethality, co-occurrence of multiple genetic events)\\n--------\\n'}",
            "2 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 9.717885255813599, 'proof tactics': ['Type unification failed: Clash of types \"_ \\\\<Rightarrow> _\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  Patient e4 :: entity \\\\<Rightarrow> bool\\nOperand:   DNA :: entity \\\\<Rightarrow> bool\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_46_2\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  PARPInhibitors :: \"entity \u21d2 bool\"\\n  DSBs :: \"entity \u21d2 bool\"\\n  SSBreakRepair :: \"entity \u21d2 bool\"\\n  HRR :: \"entity \u21d2 bool\"\\n  NHEJ :: \"entity \u21d2 bool\"\\n  DNA :: \"entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  Rely :: \"event \u21d2 bool\"\\n  Repair :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  On :: \"event \u21d2 entity \u21d2 bool\"\\n  SyntheticLethality :: \"entity \u21d2 bool\"\\n  GeneticEvents :: \"entity \u21d2 bool\"\\n  CellDeath :: \"entity \u21d2 bool\"\\n  CoOccurrence :: \"event \u21d2 bool\"\\n  Result :: \"event \u21d2 entity \u21d2 bool\"\\n  Patients :: \"entity \u21d2 bool\"\\n  LossOfPALB2 :: \"entity \u21d2 bool\"\\n  PARP1Inhibition :: \"entity \u21d2 bool\"\\n  Benefit :: \"event \u21d2 bool\"\\n  Cells :: \"entity \u21d2 bool\"\\n  Mechanism :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w v u e1 e2 e3 e4. PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z \u2227 HRR w \u2227 NHEJ v \u2227 DNA u \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Rely e3 \u2227 Agent e3 x \u2227 On e3 w \u2227 On e3 v \u2227 Repair e4 \u2227 Agent e4 x \u2227 Patient e4 u\"\\n\\n(* Explanation 2: Synthetic lethality is when co-occurrence of multiple genetic events results in cell death. *)\\naxiomatization where\\n  explanation_2: \"\u2200x y z e. SyntheticLethality x \u2227 GeneticEvents y \u2227 CellDeath z \u27f6 (CoOccurrence e \u2227 Agent e y \u2227 Result e z)\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Patients x \u2227 LossOfPALB2 x \u2227 PARP1Inhibition y \u2227 SyntheticLethality z \u2227 Cells w\"\\n  (* Hypothesis: Patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA. *)\\n  shows \"\u2203x y z w e1 e2 e3 e4. Patients x \u2227 LossOfPALB2 x \u2227 PARP1Inhibition y \u2227 SyntheticLethality z \u2227 Cells w \u2227 Benefit e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Cause e2 \u2227 Agent e2 z \u2227 Patient e2 w \u2227 Rely e3 \u2227 Agent e3 w \u2227 Mechanism e3 \u2227 Repair e4 \u2227 Agent e4 w \u2227 Patient e4 DNA\"\\nproof -\\n  (* From the premise, we have known information about patients, loss of PALB2, PARP1 inhibition, synthetic lethality, and cells. *)\\n  from asm have \"Patients x \u2227 LossOfPALB2 x \u2227 PARP1Inhibition y \u2227 SyntheticLethality z \u2227 Cells w\" <ATP>\\n  (* Explanation 2 provides a logical relation: Equivalent(E, And(F, G)), which means synthetic lethality is equivalent to the co-occurrence of multiple genetic events and cell death. *)\\n  (* From this, we can infer that synthetic lethality implies cell death and co-occurrence of multiple genetic events. *)\\n  then have \"CoOccurrence e \u2227 Agent e GeneticEvents \u2227 Result e CellDeath\" <ATP>\\n  (* Since synthetic lethality causes cell death, it implies that cells rely on a singular mechanism to repair cumulative damage to DNA. *)\\n  (* We can infer that patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality. *)\\n  then have \"Benefit e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Cause e2 \u2227 Agent e2 z \u2227 Patient e2 w \u2227 Rely e3 \u2227 Agent e3 w \u2227 Mechanism e3 \u2227 Repair e4 \u2227 Agent e4 w \u2227 Patient e4 DNA\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: PARP inhibitors cause replication\u2010associated DSBs (from Explanatory Sentence 1)\\nB: preventing SS break repair (from Explanatory Sentence 1)\\nC: relying on defective HRR (from Explanatory Sentence 1)\\nD: relying on error prone NHEJ to repair DNA (from Explanatory Sentence 1)\\nE: synthetic lethality (from Explanatory Sentence 2)\\nF: co-occurrence of multiple genetic events (from Explanatory Sentence 2)\\nG: cell death (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, And(B, Or(C, D)))\\nImplies(PARP inhibitors cause replication\u2010associated DSBs, B & (C | D))\\n--------\\nEquivalent(E, And(F, G))\\nEquivalent(synthetic lethality, F & G)\\n--------\\n\\nDerived Implications:\\nImplies(Not(G), Not(E))\\nImplies(Not(cell death), Not(synthetic lethality))\\n--------\\nImplies(Not(F), Not(E))\\nImplies(Not(co-occurrence of multiple genetic events), Not(synthetic lethality))\\n--------\\nImplies(E, G)\\nImplies(synthetic lethality, cell death)\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(preventing SS break repair), Not(PARP inhibitors cause replication\u2010associated DSBs))\\n--------\\nImplies(A, B)\\nImplies(PARP inhibitors cause replication\u2010associated DSBs, preventing SS break repair)\\n--------\\nImplies(E, F)\\nImplies(synthetic lethality, co-occurrence of multiple genetic events)\\n--------\\n'}",
            "3 iteration: {'syntactic validity': True, 'error code': '(* We know from explanation 2 that synthetic lethality implies the co-occurrence of multiple genetic events and cell death. *)\\n(* There is a logical relation Equivalent(E, And(F, G)), Equivalent(synthetic lethality, F & G) *)\\nthen have \"CoOccurrence y \u2227 CellDeath y\" sledgehammer', 'solving time': 103.27859926223755, 'proof tactics': [], 'code': 'theory clinical_46_3\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Inhibitors :: \"entity \u21d2 bool\"\\n  PARP :: \"entity \u21d2 bool\"\\n  DSBs :: \"entity \u21d2 bool\"\\n  ReplicationAssociated :: \"entity \u21d2 bool\"\\n  SSBreakRepair :: \"entity \u21d2 bool\"\\n  HRR :: \"entity \u21d2 bool\"\\n  NHEJ :: \"entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  Rely :: \"event \u21d2 bool\"\\n  On :: \"event \u21d2 entity \u21d2 bool\"\\n  Repair :: \"event \u21d2 bool\"\\n  DNA :: \"event \u21d2 bool\"\\n  SyntheticLethality :: \"entity \u21d2 bool\"\\n  GeneticEvents :: \"entity \u21d2 bool\"\\n  CoOccurrence :: \"entity \u21d2 bool\"\\n  CellDeath :: \"entity \u21d2 bool\"\\n  Result :: \"event \u21d2 bool\"\\n  Patients :: \"entity \u21d2 bool\"\\n  Loss :: \"entity \u21d2 bool\"\\n  PALB2 :: \"entity \u21d2 bool\"\\n  Inhibition :: \"entity \u21d2 bool\"\\n  PARP1 :: \"entity \u21d2 bool\"\\n  Benefit :: \"event \u21d2 bool\"\\n  Cells :: \"entity \u21d2 bool\"\\n  Mechanism :: \"event \u21d2 bool\"\\n  Damage :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w e1 e2 e3 e4. Inhibitors x \u2227 PARP x \u2227 DSBs y \u2227 ReplicationAssociated y \u2227 SSBreakRepair z \u2227 HRR w \u2227 NHEJ w \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Rely e3 \u2227 Agent e3 x \u2227 On e3 w \u2227 Repair e4 \u2227 Agent e4 x \u2227 DNA e4\"\\n\\n(* Explanation 2: Synthetic lethality is when co-occurrence of multiple genetic events results in cell death. *)\\naxiomatization where\\n  explanation_2: \"\u2200x y z e. SyntheticLethality x \u2227 GeneticEvents y \u2227 CoOccurrence y \u2227 CellDeath z \u27f6 Result e \u2227 Agent e y \u2227 Patient e z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Patients x \u2227 Loss y \u2227 PALB2 y \u2227 Inhibition z \u2227 PARP1 z \u2227 SyntheticLethality w\"\\n  (* Hypothesis: Patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA. *)\\n  shows \"\u2203x y z w e1 e2 e3 e4. Patients x \u2227 Loss y \u2227 PALB2 y \u2227 Inhibition z \u2227 PARP1 z \u2227 SyntheticLethality w \u2227 Benefit e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Cause e2 \u2227 Agent e2 w \u2227 Patient e2 y \u2227 Cells y \u2227 Rely e3 \u2227 Agent e3 y \u2227 Mechanism e3 \u2227 Repair e4 \u2227 Agent e4 y \u2227 Damage e4 \u2227 DNA e4\"\\nproof -\\n  (* From the premise, we have known information about patients, loss of PALB2, PARP1 inhibition, and synthetic lethality. *)\\n  from asm have \"Patients x \u2227 Loss y \u2227 PALB2 y \u2227 Inhibition z \u2227 PARP1 z \u2227 SyntheticLethality w\" <ATP>\\n  (* We know from explanation 2 that synthetic lethality implies the co-occurrence of multiple genetic events and cell death. *)\\n  (* There is a logical relation Equivalent(E, And(F, G)), Equivalent(synthetic lethality, F & G) *)\\n  then have \"CoOccurrence y \u2227 CellDeath y\" <ATP>\\n  (* From the derived implications, we know that synthetic lethality implies cell death and co-occurrence of multiple genetic events. *)\\n  (* Implies(E, G) and Implies(E, F) *)\\n  then have \"Result e2 \u2227 Agent e2 y \u2227 Patient e2 y\" <ATP>\\n  (* We can infer that patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality. *)\\n  (* This causes cells to rely on a singular mechanism to repair cumulative damage to DNA. *)\\n  then have \"Benefit e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Cause e2 \u2227 Agent e2 w \u2227 Patient e2 y \u2227 Cells y \u2227 Rely e3 \u2227 Agent e3 y \u2227 Mechanism e3 \u2227 Repair e4 \u2227 Agent e4 y \u2227 Damage e4 \u2227 DNA e4\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: PARP inhibitors cause replication\u2010associated DSBs (from Explanatory Sentence 1)\\nB: preventing SS break repair (from Explanatory Sentence 1)\\nC: relying on defective HRR (from Explanatory Sentence 1)\\nD: relying on error prone NHEJ to repair DNA (from Explanatory Sentence 1)\\nE: synthetic lethality (from Explanatory Sentence 2)\\nF: co-occurrence of multiple genetic events (from Explanatory Sentence 2)\\nG: cell death (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, And(B, Or(C, D)))\\nImplies(PARP inhibitors cause replication\u2010associated DSBs, B & (C | D))\\n--------\\nEquivalent(E, And(F, G))\\nEquivalent(synthetic lethality, F & G)\\n--------\\n\\nDerived Implications:\\nImplies(Not(G), Not(E))\\nImplies(Not(cell death), Not(synthetic lethality))\\n--------\\nImplies(Not(F), Not(E))\\nImplies(Not(co-occurrence of multiple genetic events), Not(synthetic lethality))\\n--------\\nImplies(E, G)\\nImplies(synthetic lethality, cell death)\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(preventing SS break repair), Not(PARP inhibitors cause replication\u2010associated DSBs))\\n--------\\nImplies(A, B)\\nImplies(PARP inhibitors cause replication\u2010associated DSBs, preventing SS break repair)\\n--------\\nImplies(E, F)\\nImplies(synthetic lethality, co-occurrence of multiple genetic events)\\n--------\\n'}",
            "4 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 9.792927980422974, 'proof tactics': ['Type unification failed: Clash of types \"event\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  Patient e1 :: entity \\\\<Rightarrow> bool\\nOperand:   z :: event\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_46_4\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Inhibitors :: \"entity \u21d2 bool\"\\n  PARP :: \"entity \u21d2 bool\"\\n  DSBs :: \"entity \u21d2 bool\"\\n  ReplicationAssociated :: \"entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  SSBreakRepair :: \"event \u21d2 bool\"\\n  Rely :: \"event \u21d2 bool\"\\n  HRR :: \"event \u21d2 bool\"\\n  Defective :: \"event \u21d2 bool\"\\n  NHEJ :: \"event \u21d2 bool\"\\n  ErrorProne :: \"event \u21d2 bool\"\\n  Repair :: \"event \u21d2 bool\"\\n  DNA :: \"event \u21d2 bool\"\\n  SyntheticLethality :: \"entity \u21d2 bool\"\\n  Occurs :: \"event \u21d2 bool\"\\n  CoOccurrence :: \"event \u21d2 bool\"\\n  GeneticEvents :: \"event \u21d2 bool\"\\n  Multiple :: \"event \u21d2 bool\"\\n  LossOfPALB2 :: \"entity \u21d2 bool\"\\n  Result :: \"event \u21d2 bool\"\\n  CellDeath :: \"event \u21d2 bool\"\\n  Mechanism :: \"event \u21d2 bool\"\\n  Singular :: \"event \u21d2 bool\"\\n  Damage :: \"event \u21d2 bool\"\\n  Cells :: \"entity \u21d2 bool\"\\n  Lead :: \"event \u21d2 event \u21d2 bool\"\\n  Combined :: \"event \u21d2 bool\"\\n  Inhibition :: \"event \u21d2 bool\"\\n  PARP1 :: \"event \u21d2 bool\"\\n  Force :: \"event \u21d2 bool\"\\n  Depend :: \"event \u21d2 bool\"\\n  Inadequate :: \"event \u21d2 bool\"\\n  Patients :: \"entity \u21d2 bool\"\\n  Benefit :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error-prone NHEJ to repair DNA. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e1 e2 e3 e4 e5. Inhibitors x \u2227 PARP x \u2227 DSBs y \u2227 ReplicationAssociated y \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 SSBreakRepair e2 \u2227 Rely e3 \u2227 HRR e4 \u2227 Defective e4 \u2227 NHEJ e5 \u2227 ErrorProne e5 \u2227 Repair e3 \u2227 DNA e3\"\\n\\n(* Explanation 2: Synthetic lethality occurs when the co-occurrence of multiple genetic events, such as the loss of PALB2, results in cell death due to the reliance on a singular mechanism to repair cumulative DNA damage. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2 e3 e4 e5. SyntheticLethality x \u2227 Occurs e1 \u2227 CoOccurrence e2 \u2227 GeneticEvents e2 \u2227 Multiple e2 \u2227 LossOfPALB2 y \u2227 Result e3 \u2227 CellDeath e3 \u2227 Rely e4 \u2227 Mechanism e5 \u2227 Singular e5 \u2227 Repair e5 \u2227 Damage e5 \u2227 DNA e5\"\\n\\n(* Explanation 3: The loss of PALB2 in cells can lead to synthetic lethality when combined with PARP1 inhibition, as it forces cells to depend on a singular, often inadequate, DNA repair mechanism, leading to cell death. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z e1 e2 e3 e4 e5 e6. LossOfPALB2 x \u2227 Cells y \u2227 Lead e1 e2 \u2227 SyntheticLethality x \u2227 Combined e3 \u2227 Inhibition e3 \u2227 PARP1 e3 \u2227 Force e4 \u2227 Cells y \u2227 Depend e5 \u2227 Mechanism e6 \u2227 Singular e6 \u2227 Inadequate e6 \u2227 Repair e6 \u2227 DNA e6 \u2227 Lead e4 e5 \u2227 CellDeath e5\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Patients x \u2227 LossOfPALB2 y \u2227 Inhibition z \u2227 PARP1 z\"\\n  (* Hypothesis: Patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA *)\\n  shows \"\u2203x y z e1 e2 e3 e4. Patients x \u2227 LossOfPALB2 y \u2227 Inhibition z \u2227 PARP1 z \u2227 Benefit e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 SyntheticLethality y \u2227 Cause e2 e3 \u2227 Cells e3 \u2227 Rely e3 \u2227 Mechanism e4 \u2227 Singular e4 \u2227 Repair e4 \u2227 Damage e4 \u2227 DNA e4\"\\nproof -\\n  (* From the premise, we have known information about patients, loss of PALB2, and PARP1 inhibition. *)\\n  from asm have \"Patients x \u2227 LossOfPALB2 y \u2227 Inhibition z \u2227 PARP1 z\" <ATP>\\n  (* Explanation 3 states that the loss of PALB2 in cells can lead to synthetic lethality when combined with PARP1 inhibition, forcing cells to depend on a singular, often inadequate, DNA repair mechanism, leading to cell death. *)\\n  (* This corresponds to logical relation Implies(And(I, J), And(K, G)), which implies that loss of PALB2 and PARP1 inhibition lead to cell death and reliance on a singular mechanism. *)\\n  then have \"SyntheticLethality y \u2227 Cells e3 \u2227 Rely e3 \u2227 Mechanism e4 \u2227 Singular e4 \u2227 Repair e4 \u2227 Damage e4 \u2227 DNA e4\" <ATP>\\n  (* From this, we can infer that patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality. *)\\n  then have \"Benefit e1 \u2227 Agent e1 x \u2227 Patient e1 z\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: PARP inhibitors cause replication\u2010associated DSBs (from Explanatory Sentence 1)\\nB: preventing SS break repair (from Explanatory Sentence 1)\\nC: relying on defective HRR and error-prone NHEJ to repair DNA (from Explanatory Sentence 1)\\nD: synthetic lethality occurs (from Explanatory Sentence 2)\\nE: co-occurrence of multiple genetic events (from Explanatory Sentence 2)\\nF: loss of PALB2 (from Explanatory Sentence 2)\\nG: cell death (from Explanatory Sentence 2)\\nH: reliance on a singular mechanism to repair cumulative DNA damage (from Explanatory Sentence 2)\\nI: loss of PALB2 in cells (from Explanatory Sentence 3)\\nJ: PARP1 inhibition (from Explanatory Sentence 3)\\nK: forces cells to depend on a singular, often inadequate, DNA repair mechanism (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(A, And(B, C))\\nImplies(PARP inhibitors cause replication\u2010associated DSBs, B & C)\\n--------\\nImplies(And(E, F), And(D, G))\\nImplies(E & F, D & G)\\n--------\\nImplies(And(I, J), And(K, G))\\nImplies(I & J, G & K)\\n--------\\n\\nDerived Implications:\\nImplies(A, C)\\nImplies(PARP inhibitors cause replication\u2010associated DSBs, relying on defective HRR and error-prone NHEJ to repair DNA)\\n--------\\nImplies(A, B)\\nImplies(PARP inhibitors cause replication\u2010associated DSBs, preventing SS break repair)\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(relying on defective HRR and error-prone NHEJ to repair DNA), Not(PARP inhibitors cause replication\u2010associated DSBs))\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(preventing SS break repair), Not(PARP inhibitors cause replication\u2010associated DSBs))\\n--------\\n'}",
            "5 iteration: {'syntactic validity': True, 'error code': '(* Explanation 3 provides a logical relation: Implies(And(I, J), And(D, K, G)), which means the loss of PALB2 in cells and PARP1 inhibition leads to synthetic lethality, forcing cells to depend on a singular, often inadequate, DNA repair mechanism, and cell death. *)\\n(* Since we have LossOfPALB2 x and PARP1Inhibition y, we can infer the consequences of synthetic lethality and reliance on a singular mechanism. *)\\nthen have \"SyntheticLethality z \u2227 Depend e3 \u2227 Agent e3 x \u2227 Mechanism w \u2227 On e3 w \u2227 Repair e4 \u2227 Agent e4 x \u2227 Patient e4 v1 \u2227 DNA v1\" sledgehammer', 'solving time': 103.31451153755188, 'proof tactics': [], 'code': 'theory clinical_46_5\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  PARPInhibitors :: \"entity \u21d2 bool\"\\n  DSBs :: \"entity \u21d2 bool\"\\n  SSBreakRepair :: \"entity \u21d2 bool\"\\n  DNA :: \"entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  Rely :: \"event \u21d2 bool\"\\n  On :: \"event \u21d2 entity \u21d2 bool\"\\n  HRR :: \"entity \u21d2 bool\"\\n  NHEJ :: \"entity \u21d2 bool\"\\n  Repair :: \"event \u21d2 bool\"\\n  SyntheticLethality :: \"entity \u21d2 bool\"\\n  GeneticEvents :: \"entity \u21d2 bool\"\\n  LossOfPALB2 :: \"entity \u21d2 bool\"\\n  CellDeath :: \"entity \u21d2 bool\"\\n  Occurs :: \"event \u21d2 bool\"\\n  CoOccurrence :: \"event \u21d2 bool\"\\n  Results :: \"event \u21d2 bool\"\\n  Reliance :: \"event \u21d2 bool\"\\n  Mechanism :: \"entity \u21d2 bool\"\\n  Cells :: \"entity \u21d2 bool\"\\n  PARP1Inhibition :: \"entity \u21d2 bool\"\\n  Lead :: \"event \u21d2 bool\"\\n  Combined :: \"event \u21d2 bool\"\\n  Force :: \"event \u21d2 bool\"\\n  Depend :: \"event \u21d2 bool\"\\n  Leading :: \"event \u21d2 bool\"\\n  Patients :: \"entity \u21d2 bool\"\\n  Benefit :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error-prone NHEJ to repair DNA. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w e1 e2 e3 e4 v1 v2. PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z \u2227 DNA w \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Rely e3 \u2227 Agent e3 x \u2227 On e3 v1 \u2227 HRR v1 \u2227 On e3 v2 \u2227 NHEJ v2 \u2227 Repair e4 \u2227 Agent e4 x \u2227 Patient e4 w\"\\n\\n(* Explanation 2: Synthetic lethality occurs when the co-occurrence of multiple genetic events, such as the loss of PALB2, results in cell death due to the reliance on a singular mechanism to repair cumulative DNA damage. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z w e1 e2 e3 e4 e5 v. SyntheticLethality x \u2227 GeneticEvents y \u2227 LossOfPALB2 z \u2227 CellDeath w \u2227 Occurs e1 \u2227 Agent e1 x \u2227 CoOccurrence e2 \u2227 Agent e2 y \u2227 Results e3 \u2227 Agent e3 y \u2227 Patient e3 w \u2227 Reliance e4 \u2227 Agent e4 y \u2227 Mechanism v \u2227 On e4 v \u2227 Repair e5 \u2227 Agent e5 y \u2227 Patient e5 v1 \u2227 DNA v1\"\\n\\n(* Explanation 3: The loss of PALB2 in cells can lead to synthetic lethality when combined with PARP1 inhibition, as it forces cells to depend on a singular, often inadequate, DNA repair mechanism, leading to cell death. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z w v u e1 e2 e3 e4 e5 e6 v1. LossOfPALB2 x \u2227 Cells y \u2227 SyntheticLethality z \u2227 PARP1Inhibition w \u2227 CellDeath v \u2227 Lead e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Combined e2 \u2227 Agent e2 x \u2227 Patient e2 w \u2227 Force e3 \u2227 Agent e3 x \u2227 Patient e3 y \u2227 Depend e4 \u2227 Agent e4 y \u2227 Mechanism u \u2227 On e4 u \u2227 Repair e5 \u2227 Agent e5 y \u2227 Patient e5 v1 \u2227 DNA v1 \u2227 Leading e6 \u2227 Agent e6 y \u2227 Patient e6 v\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Patients x \u2227 LossOfPALB2 x \u2227 PARP1Inhibition y \u2227 SyntheticLethality z\"\\n  (* Hypothesis: Patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA. *)\\n  shows \"\u2203x y z e1 e2 e3 e4 w v1. Patients x \u2227 LossOfPALB2 x \u2227 PARP1Inhibition y \u2227 SyntheticLethality z \u2227 Benefit e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Cause e2 \u2227 Agent e2 z \u2227 Patient e2 x \u2227 Rely e3 \u2227 Agent e3 x \u2227 Mechanism w \u2227 On e3 w \u2227 Repair e4 \u2227 Agent e4 x \u2227 Patient e4 v1 \u2227 DNA v1\"\\nproof -\\n  (* From the premise, we have known information about patients, loss of PALB2, PARP1 inhibition, and synthetic lethality. *)\\n  from asm have \"Patients x \u2227 LossOfPALB2 x \u2227 PARP1Inhibition y \u2227 SyntheticLethality z\" <ATP>\\n  (* Explanation 3 provides a logical relation: Implies(And(I, J), And(D, K, G)), which means the loss of PALB2 in cells and PARP1 inhibition leads to synthetic lethality, forcing cells to depend on a singular, often inadequate, DNA repair mechanism, and cell death. *)\\n  (* Since we have LossOfPALB2 x and PARP1Inhibition y, we can infer the consequences of synthetic lethality and reliance on a singular mechanism. *)\\n  then have \"SyntheticLethality z \u2227 Depend e3 \u2227 Agent e3 x \u2227 Mechanism w \u2227 On e3 w \u2227 Repair e4 \u2227 Agent e4 x \u2227 Patient e4 v1 \u2227 DNA v1\" <ATP>\\n  (* The hypothesis requires showing that patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA. *)\\n  (* We have already established the reliance on a singular mechanism and synthetic lethality. *)\\n  (* Therefore, we can conclude that patients may benefit from this mechanism. *)\\n  then have \"Benefit e1 \u2227 Agent e1 x \u2227 Patient e1 y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: PARP inhibitors cause replication\u2010associated DSBs (from Explanatory Sentence 1)\\nB: preventing SS break repair (from Explanatory Sentence 1)\\nC: relying on defective HRR and error-prone NHEJ to repair DNA (from Explanatory Sentence 1)\\nD: synthetic lethality occurs (from Explanatory Sentence 2)\\nE: co-occurrence of multiple genetic events (from Explanatory Sentence 2)\\nF: loss of PALB2 (from Explanatory Sentence 2)\\nG: cell death (from Explanatory Sentence 2)\\nH: reliance on a singular mechanism to repair cumulative DNA damage (from Explanatory Sentence 2)\\nI: loss of PALB2 in cells (from Explanatory Sentence 3)\\nJ: PARP1 inhibition (from Explanatory Sentence 3)\\nK: forces cells to depend on a singular, often inadequate, DNA repair mechanism (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(A, And(B, C))\\nImplies(PARP inhibitors cause replication\u2010associated DSBs, B & C)\\n--------\\nImplies(And(E, F), And(D, G, H))\\nImplies(E & F, D & G & H)\\n--------\\nImplies(And(I, J), And(D, K, G))\\nImplies(I & J, D & G & K)\\n--------\\n\\nDerived Implications:\\nImplies(A, C)\\nImplies(PARP inhibitors cause replication\u2010associated DSBs, relying on defective HRR and error-prone NHEJ to repair DNA)\\n--------\\nImplies(A, B)\\nImplies(PARP inhibitors cause replication\u2010associated DSBs, preventing SS break repair)\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(relying on defective HRR and error-prone NHEJ to repair DNA), Not(PARP inhibitors cause replication\u2010associated DSBs))\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(preventing SS break repair), Not(PARP inhibitors cause replication\u2010associated DSBs))\\n--------\\n'}",
            "6 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 4.0181591510772705, 'proof tactics': ['Type unification failed: Clash of types \"entity\" and \"event\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  Cause :: event \\\\<Rightarrow> bool\\nOperand:   e2 :: entity\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_46_6\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  PARPInhibitors :: \"entity \u21d2 bool\"\\n  Breaks :: \"entity \u21d2 bool\"\\n  DoubleStrand :: \"entity \u21d2 bool\"\\n  ReplicationAssociated :: \"entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  Repair :: \"event \u21d2 bool\"\\n  SingleStrand :: \"entity \u21d2 bool\"\\n  Force :: \"event \u21d2 bool\"\\n  Cells :: \"entity \u21d2 bool\"  (* Changed from entity to entity \u21d2 bool *)\\n  Rely :: \"event \u21d2 bool\"\\n  HomologousRecombination :: \"event \u21d2 bool\"\\n  Defective :: \"event \u21d2 bool\"\\n  NonHomologousEndJoining :: \"event \u21d2 bool\"\\n  ErrorProne :: \"event \u21d2 bool\"\\n  DNA :: \"entity \u21d2 bool\"  (* Changed from entity to entity \u21d2 bool *)\\n  SyntheticLethality :: \"entity \u21d2 bool\"\\n  Occur :: \"event \u21d2 bool\"\\n  CoOccurrence :: \"entity \u21d2 bool\"\\n  GeneticEvents :: \"entity \u21d2 bool\"\\n  Multiple :: \"entity \u21d2 bool\"\\n  LossOfPALB2 :: \"entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Result :: \"event \u21d2 bool\"\\n  CellDeath :: \"entity \u21d2 bool\"  (* Changed from entity to entity \u21d2 bool *)\\n  Mechanism :: \"entity \u21d2 bool\"\\n  Singular :: \"entity \u21d2 bool\"\\n  PARP1Inhibition :: \"entity \u21d2 bool\"\\n  Combine :: \"event \u21d2 bool\"\\n  Depend :: \"event \u21d2 bool\"\\n  Inadequate :: \"entity \u21d2 bool\"\\n  Lead :: \"event \u21d2 bool\"\\n  TherapeuticWindow :: \"entity \u21d2 bool\"\\n  Create :: \"event \u21d2 bool\"\\n  Patients :: \"entity \u21d2 bool\"\\n  Benefit :: \"event \u21d2 bool\"\\n  Treatment :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: PARP inhibitors cause replication\u2010associated double-strand breaks by preventing single-strand break repair, which forces cells to rely on defective homologous recombination repair and error-prone non-homologous end joining to repair DNA. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e1 e2 e3 e4 e5. PARPInhibitors x \u2227 Breaks y \u2227 DoubleStrand y \u2227 ReplicationAssociated y \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Repair e2 \u2227 SingleStrand z \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Force e3 \u2227 Agent e3 x \u2227 Patient e3 c \u2227 Cells c \u2227 Rely e4 \u2227 Agent e4 c \u2227 Cells c \u2227 Repair e5 \u2227 HomologousRecombination e5 \u2227 Defective e5 \u2227 NonHomologousEndJoining e5 \u2227 ErrorProne e5 \u2227 Patient e5 d \u2227 DNA d\"\\n\\n(* Explanation 2: Synthetic lethality occurs when the co-occurrence of multiple genetic events, such as the loss of PALB2, results in cell death due to the reliance on a singular mechanism to repair cumulative DNA damage. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2 e3 e4. SyntheticLethality x \u2227 Occur e1 \u2227 Agent e1 x \u2227 CoOccurrence y \u2227 GeneticEvents y \u2227 Multiple y \u2227 LossOfPALB2 z \u2227 In y z \u2227 Result e2 \u2227 Agent e2 y \u2227 Patient e2 cd \u2227 CellDeath cd \u2227 Rely e3 \u2227 Agent e3 c \u2227 Cells c \u2227 Mechanism w \u2227 Singular w \u2227 Repair e4 \u2227 Agent e4 w \u2227 Patient e4 d \u2227 DNA d\"\\n\\n(* Explanation 3: The loss of PALB2 in cells can lead to synthetic lethality when combined with PARP1 inhibition, as it forces cells to depend on a singular, often inadequate, DNA repair mechanism, leading to cell death. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z e1 e2 e3 e4 e5. LossOfPALB2 x \u2227 In x c \u2227 Cells c \u2227 SyntheticLethality y \u2227 Lead e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 PARP1Inhibition z \u2227 Combine e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Force e3 \u2227 Agent e3 x \u2227 Patient e3 c \u2227 Cells c \u2227 Depend e4 \u2227 Agent e4 c \u2227 Cells c \u2227 Mechanism w \u2227 Singular w \u2227 Inadequate w \u2227 Repair e5 \u2227 Agent e5 w \u2227 Patient e5 d \u2227 DNA d \u2227 Lead e6 \u2227 Agent e6 w \u2227 Patient e6 cd \u2227 CellDeath cd\"\\n\\n(* Explanation 4: When cells with a loss of PALB2 rely on a singular DNA repair mechanism due to PARP1 inhibition, this can create a therapeutic window where patients may benefit from the treatment, as the inadequate repair mechanism leads to cell death. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y z w e1 e2 e3 e4 e5 e6. Cells x \u2227 LossOfPALB2 y \u2227 In x y \u2227 Mechanism z \u2227 Singular z \u2227 Repair e1 \u2227 Agent e1 z \u2227 Patient e1 d \u2227 DNA d \u2227 Rely e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 PARP1Inhibition w \u2227 DueTo e2 w \u2227 TherapeuticWindow v \u2227 Create e3 \u2227 Agent e3 x \u2227 Patient e3 v \u2227 Patients u \u2227 Benefit e4 \u2227 Agent e4 u \u2227 Treatment t \u2227 Patient e4 t \u2227 Mechanism z \u2227 Inadequate z \u2227 Lead e5 \u2227 Agent e5 z \u2227 Patient e5 cd \u2227 CellDeath cd\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Patients x \u2227 LossOfPALB2 y \u2227 In x y \u2227 PARP1Inhibition z\"\\n  (* Hypothesis: Patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA. *)\\n  shows \"\u2203x y z e1 e2 e3. Patients x \u2227 LossOfPALB2 y \u2227 In x y \u2227 PARP1Inhibition z \u2227 Benefit e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 SyntheticLethality e2 \u2227 Cause e2 e3 \u2227 Rely e3 \u2227 Agent e3 c \u2227 Cells c \u2227 Mechanism w \u2227 Singular w \u2227 Repair e4 \u2227 Agent e4 w \u2227 Patient e4 d \u2227 DNA d\"\\nproof -\\n  (* From the known information, we have LossOfPALB2 y and PARP1Inhibition z *)\\n  from asm have \"LossOfPALB2 y \u2227 PARP1Inhibition z\" <ATP>\\n  (* Using the logical relation Implies(And(G, J), And(I, H)), we infer reliance on a singular DNA repair mechanism and cell death *)\\n  then have \"Reliance on a singular DNA repair mechanism \u2227 Cell death occurs\" <ATP>\\n  (* Using the logical relation Implies(And(G, J), K), we infer a therapeutic window is created *)\\n  then have \"Therapeutic window is created\" <ATP>\\n  (* Using the logical relation Implies(K, L), we infer patients benefit from treatment *)\\n  then have \"Patients benefit from treatment\" <ATP>\\n  (* Therefore, we can conclude the hypothesis *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: PARP inhibitors prevent single-strand break repair (from Explanatory Sentence 1)\\nB: Replication-associated double-strand breaks occur (from Explanatory Sentence 1)\\nC: Cells rely on defective homologous recombination repair (from Explanatory Sentence 1)\\nD: Cells rely on error-prone non-homologous end joining (from Explanatory Sentence 1)\\nE: Synthetic lethality occurs (from Explanatory Sentence 2)\\nF: Co-occurrence of multiple genetic events (from Explanatory Sentence 2)\\nG: Loss of PALB2 (from Explanatory Sentence 2)\\nH: Cell death occurs (from Explanatory Sentence 2)\\nI: Reliance on a singular DNA repair mechanism (from Explanatory Sentence 2)\\nJ: PARP1 inhibition (from Explanatory Sentence 3)\\nK: Therapeutic window is created (from Explanatory Sentence 4)\\nL: Patients benefit from treatment (from Explanatory Sentence 4)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(PARP inhibitors prevent single-strand break repair, Replication-associated double-strand breaks occur)\\n--------\\nImplies(B, Or(C, D))\\nImplies(Replication-associated double-strand breaks occur, C | D)\\n--------\\nImplies(And(F, G), E)\\nImplies(F & G, Synthetic lethality occurs)\\n--------\\nImplies(E, And(I, H))\\nImplies(Synthetic lethality occurs, H & I)\\n--------\\nImplies(And(G, J), And(I, H))\\nImplies(G & J, H & I)\\n--------\\nImplies(And(G, J), K)\\nImplies(G & J, Therapeutic window is created)\\n--------\\nImplies(K, L)\\nImplies(Therapeutic window is created, Patients benefit from treatment)\\n--------\\n\\nDerived Implications:\\nImplies(Not(H), Not(E))\\nImplies(Not(Cell death occurs), Not(Synthetic lethality occurs))\\n--------\\nImplies(E, H)\\nImplies(Synthetic lethality occurs, Cell death occurs)\\n--------\\nImplies(E, I)\\nImplies(Synthetic lethality occurs, Reliance on a singular DNA repair mechanism)\\n--------\\nImplies(Not(I), Not(E))\\nImplies(Not(Reliance on a singular DNA repair mechanism), Not(Synthetic lethality occurs))\\n--------\\n'}",
            "7 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 2.2700533866882324, 'proof tactics': ['Type unification failed: Clash of types \"entity\" and \"event\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  Cause :: event \\\\<Rightarrow> bool\\nOperand:   e2 :: entity\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_46_7\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Inhibitors :: \"entity \u21d2 bool\"\\n  PARP :: \"entity \u21d2 bool\"\\n  Breaks :: \"entity \u21d2 bool\"\\n  DoubleStrand :: \"entity \u21d2 bool\"\\n  ReplicationAssociated :: \"entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  Repair :: \"event \u21d2 bool\"\\n  SingleStrand :: \"entity \u21d2 bool\"\\n  Force :: \"event \u21d2 bool\"\\n  Cells :: \"entity \u21d2 bool\"\\n  Rely :: \"event \u21d2 bool\"\\n  HomologousRecombination :: \"event \u21d2 bool\"\\n  Defective :: \"event \u21d2 bool\"\\n  NonHomologousEndJoining :: \"event \u21d2 bool\"\\n  ErrorProne :: \"event \u21d2 bool\"\\n  On :: \"entity \u21d2 event \u21d2 bool\"\\n  DNA :: \"entity \u21d2 bool\"\\n  SyntheticLethality :: \"entity \u21d2 bool\"\\n  Occurs :: \"event \u21d2 bool\"\\n  CoOccurrence :: \"entity \u21d2 bool\"\\n  GeneticEvents :: \"entity \u21d2 bool\"\\n  Multiple :: \"entity \u21d2 bool\"\\n  LossOfPALB2 :: \"entity \u21d2 bool\"\\n  SuchAs :: \"entity \u21d2 entity \u21d2 bool\"\\n  Result :: \"event \u21d2 bool\"\\n  Death :: \"entity \u21d2 bool\"\\n  Cell :: \"entity \u21d2 bool\"\\n  Mechanism :: \"event \u21d2 bool\"\\n  Singular :: \"event \u21d2 bool\"\\n  Damage :: \"entity \u21d2 bool\"\\n  Cumulative :: \"entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Lead :: \"event \u21d2 bool\"\\n  Combine :: \"event \u21d2 bool\"\\n  Inhibition :: \"entity \u21d2 bool\"\\n  PARP1 :: \"entity \u21d2 bool\"\\n  With :: \"event \u21d2 entity \u21d2 bool\"\\n  Depend :: \"event \u21d2 bool\"\\n  Inadequate :: \"event \u21d2 bool\"\\n  Create :: \"event \u21d2 bool\"\\n  Window :: \"entity \u21d2 bool\"\\n  Therapeutic :: \"entity \u21d2 bool\"\\n  Patients :: \"entity \u21d2 bool\"\\n  Benefit :: \"event \u21d2 bool\"\\n  Treatment :: \"entity \u21d2 bool\"\\n  From :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: PARP inhibitors cause replication\u2010associated double-strand breaks by preventing single-strand break repair, which forces cells to rely on defective homologous recombination repair and error-prone non-homologous end joining to repair DNA. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w e1 e2 e3 e4 e5 e6. Inhibitors x \u2227 PARP x \u2227 Breaks y \u2227 DoubleStrand y \u2227 ReplicationAssociated y \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Repair e2 \u2227 SingleStrand z \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Force e3 \u2227 Cells w \u2227 Agent e3 x \u2227 Rely e4 \u2227 Agent e4 w \u2227 Repair e5 \u2227 HomologousRecombination e5 \u2227 Defective e5 \u2227 Repair e6 \u2227 NonHomologousEndJoining e6 \u2227 ErrorProne e6 \u2227 On w e5 \u2227 On w e6 \u2227 Repair e5 \u2227 Repair e6 \u2227 Patient e5 z \u2227 Patient e6 z \u2227 DNA z\"\\n\\n(* Explanation 2: Synthetic lethality occurs when the co-occurrence of multiple genetic events, such as the loss of PALB2, results in cell death due to the reliance on a singular mechanism to repair cumulative DNA damage. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z w e1 e2 e3 e4. SyntheticLethality x \u2227 Occurs e1 \u2227 Agent e1 x \u2227 CoOccurrence y \u2227 GeneticEvents y \u2227 Multiple y \u2227 LossOfPALB2 z \u2227 SuchAs y z \u2227 Result e2 \u2227 Agent e2 y \u2227 Death w \u2227 Cell w \u2227 Patient e2 w \u2227 Rely e3 \u2227 Mechanism e4 \u2227 Singular e4 \u2227 On w e4 \u2227 Repair e4 \u2227 Patient e4 w \u2227 Damage w \u2227 Cumulative w \u2227 DNA w\"\\n\\n(* Explanation 3: The loss of PALB2 in cells can lead to synthetic lethality when combined with PARP1 inhibition, as it forces cells to depend on a singular, often inadequate, DNA repair mechanism, leading to cell death. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z w e1 e2 e3 e4 e5. LossOfPALB2 x \u2227 Cells y \u2227 In x y \u2227 Lead e1 \u2227 Agent e1 x \u2227 SyntheticLethality z \u2227 Patient e1 z \u2227 Combine e2 \u2227 Inhibition w \u2227 PARP1 w \u2227 With e2 w \u2227 Force e3 \u2227 Agent e3 x \u2227 Cells y \u2227 Depend e4 \u2227 Agent e4 y \u2227 Mechanism e5 \u2227 Singular e5 \u2227 Inadequate e5 \u2227 On y e5 \u2227 Repair e5 \u2227 Patient e5 y \u2227 Lead e5 \u2227 Death z \u2227 Cell z \u2227 Patient e5 z\"\\n\\n(* Explanation 4: When cells with a loss of PALB2 rely on a singular DNA repair mechanism due to PARP1 inhibition, this can create a therapeutic window where patients may benefit from the treatment, as the inadequate repair mechanism leads to cell death. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y z w v e1 e2 e3 e4 e5 e6. Cells x \u2227 LossOfPALB2 y \u2227 In x y \u2227 Rely e1 \u2227 Agent e1 x \u2227 Mechanism e2 \u2227 Singular e2 \u2227 On x e2 \u2227 Repair e2 \u2227 Patient e2 x \u2227 Inhibition w \u2227 PARP1 w \u2227 DueTo e3 \u2227 Agent e3 x \u2227 Patient e3 w \u2227 Create e4 \u2227 Agent e4 x \u2227 Window v \u2227 Therapeutic v \u2227 Patient e4 v \u2227 Patients y \u2227 Benefit e5 \u2227 Agent e5 y \u2227 Treatment z \u2227 From y z \u2227 Mechanism e6 \u2227 Inadequate e6 \u2227 Lead e6 \u2227 Agent e6 y \u2227 Death w \u2227 Cell w \u2227 Patient e6 w\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Patients x \u2227 LossOfPALB2 x \u2227 Inhibition y \u2227 PARP1 y\"\\n  (* Hypothesis: Patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA. *)\\n  shows \"\u2203x y z e1 e2 e3 e4. Patients x \u2227 LossOfPALB2 x \u2227 Inhibition y \u2227 PARP1 y \u2227 Benefit e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 SyntheticLethality e2 \u2227 Cause e2 e3 \u2227 Cells z \u2227 Rely e3 \u2227 Agent e3 z \u2227 Mechanism e4 \u2227 Singular e4 \u2227 On z e4 \u2227 Repair e4 \u2227 Patient e4 z \u2227 Damage z \u2227 Cumulative z \u2227 DNA z\"\\nproof -\\n  (* From the premise, we have known information about patients, loss of PALB2, inhibition, and PARP1. *)\\n  from asm have \"Patients x \u2227 LossOfPALB2 x \u2227 Inhibition y \u2227 PARP1 y\" <ATP>\\n  (* There is a logical relation Implies(And(G, J), K), Implies(G & J, Therapeutic window is created) *)\\n  (* G is Loss of PALB2, J is PARP1 inhibition, and K is Therapeutic window is created. *)\\n  (* We already have LossOfPALB2 x and PARP1 y, so we can infer that a therapeutic window is created. *)\\n  then have \"Therapeutic window is created\" <ATP>\\n  (* There is a logical relation Implies(K, L), Implies(Therapeutic window is created, Patients benefit from treatment) *)\\n  (* K is Therapeutic window is created, L is Patients benefit from treatment. *)\\n  (* We can infer that patients benefit from treatment. *)\\n  then have \"Patients benefit from treatment\" <ATP>\\n  (* There is a logical relation Implies(And(G, J), I), Implies(G & J, Reliance on a singular DNA repair mechanism) *)\\n  (* We already have LossOfPALB2 x and PARP1 y, so we can infer reliance on a singular DNA repair mechanism. *)\\n  then have \"Reliance on a singular DNA repair mechanism\" <ATP>\\n  (* There is a logical relation Implies(I, H), Implies(Reliance on a singular DNA repair mechanism, Cell death occurs) *)\\n  (* We can infer that cell death occurs. *)\\n  then have \"Cell death occurs\" <ATP>\\n  (* There is a logical relation Implies(And(F, G), E), Implies(F & G, Synthetic lethality occurs) *)\\n  (* We already have LossOfPALB2 x, so we can infer synthetic lethality occurs. *)\\n  then have \"Synthetic lethality occurs\" <ATP>\\n  (* We have all the necessary components to prove the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: PARP inhibitors prevent single-strand break repair (from Explanatory Sentence 1)\\nB: Replication-associated double-strand breaks occur (from Explanatory Sentence 1)\\nC: Cells rely on defective homologous recombination repair (from Explanatory Sentence 1)\\nD: Cells rely on error-prone non-homologous end joining (from Explanatory Sentence 1)\\nE: Synthetic lethality occurs (from Explanatory Sentence 2)\\nF: Co-occurrence of multiple genetic events (from Explanatory Sentence 2)\\nG: Loss of PALB2 (from Explanatory Sentence 2)\\nH: Cell death occurs (from Explanatory Sentence 2)\\nI: Reliance on a singular DNA repair mechanism (from Explanatory Sentence 2)\\nJ: PARP1 inhibition (from Explanatory Sentence 3)\\nK: Therapeutic window is created (from Explanatory Sentence 4)\\nL: Patients benefit from treatment (from Explanatory Sentence 4)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(PARP inhibitors prevent single-strand break repair, Replication-associated double-strand breaks occur)\\n--------\\nImplies(B, Or(C, D))\\nImplies(Replication-associated double-strand breaks occur, C | D)\\n--------\\nImplies(And(F, G), E)\\nImplies(F & G, Synthetic lethality occurs)\\n--------\\nImplies(E, H)\\nImplies(Synthetic lethality occurs, Cell death occurs)\\n--------\\nImplies(And(G, J), I)\\nImplies(G & J, Reliance on a singular DNA repair mechanism)\\n--------\\nImplies(I, H)\\nImplies(Reliance on a singular DNA repair mechanism, Cell death occurs)\\n--------\\nImplies(And(G, J), K)\\nImplies(G & J, Therapeutic window is created)\\n--------\\nImplies(K, L)\\nImplies(Therapeutic window is created, Patients benefit from treatment)\\n--------\\n\\nDerived Implications:\\n'}",
            "8 iteration: {'syntactic validity': True, 'error code': '(* Explanation 3 and the logical relation Implies(And(G, I), J) allow us to infer reliance on a singular DNA repair mechanism. *)\\nthen have \"Rely e3 \u2227 Agent e3 x \u2227 Mechanism z \u2227 Repair e3 \u2227 Damage z \u2227 DNA z\" sledgehammer', 'solving time': 103.418536901474, 'proof tactics': [], 'code': 'theory clinical_46_8\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  PARPInhibitors :: \"entity \u21d2 bool\"\\n  DoubleStrandBreaks :: \"entity \u21d2 bool\"\\n  SingleStrandBreakRepair :: \"entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  Force :: \"event \u21d2 bool\"\\n  Rely :: \"event \u21d2 bool\"\\n  HomologousRecombinationRepair :: \"entity \u21d2 bool\"\\n  NonHomologousEndJoining :: \"entity \u21d2 bool\"\\n  Repair :: \"event \u21d2 bool\"\\n  DNA :: \"entity \u21d2 bool\"\\n  SyntheticLethality :: \"entity \u21d2 bool\"\\n  GeneticEvents :: \"entity \u21d2 bool\"\\n  LossOfPALB2 :: \"entity \u21d2 bool\"\\n  Occur :: \"event \u21d2 bool\"\\n  CoOccurrence :: \"event \u21d2 bool\"\\n  Result :: \"event \u21d2 bool\"\\n  CellDeath :: \"entity \u21d2 bool\"\\n  Mechanism :: \"entity \u21d2 bool\"\\n  Damage :: \"entity \u21d2 bool\"\\n  Cells :: \"entity \u21d2 bool\"\\n  PARP1Inhibition :: \"entity \u21d2 bool\"\\n  Lead :: \"event \u21d2 bool\"\\n  Combine :: \"event \u21d2 bool\"\\n  Depend :: \"event \u21d2 bool\"\\n  Inadequate :: \"entity \u21d2 bool\"\\n  TherapeuticWindow :: \"entity \u21d2 bool\"\\n  Patients :: \"entity \u21d2 bool\"\\n  Treatment :: \"entity \u21d2 bool\"\\n  DueTo :: \"event \u21d2 bool\"\\n  Create :: \"event \u21d2 bool\"\\n  Benefit :: \"event \u21d2 bool\"\\n  Source :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: PARP inhibitors cause replication\u2010associated double-strand breaks by preventing single-strand break repair, which forces cells to rely on defective homologous recombination repair and error-prone non-homologous end joining to repair DNA. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e1 e2 e3 e4. PARPInhibitors x \u2227 DoubleStrandBreaks y \u2227 SingleStrandBreakRepair z \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Force e3 \u2227 Agent e3 x \u2227 Patient e3 y \u2227 Rely e4 \u2227 Agent e4 y \u2227 HomologousRecombinationRepair z \u2227 NonHomologousEndJoining z \u2227 Repair e4 \u2227 DNA z\"\\n\\n(* Explanation 2: Synthetic lethality occurs when the co-occurrence of multiple genetic events, such as the loss of PALB2, results in cell death due to the reliance on a singular mechanism to repair cumulative DNA damage. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2 e3. SyntheticLethality x \u2227 GeneticEvents y \u2227 LossOfPALB2 z \u2227 Occur e1 \u2227 Agent e1 x \u2227 CoOccurrence e2 \u2227 Agent e2 y \u2227 Result e3 \u2227 Agent e3 y \u2227 Patient e3 z \u2227 CellDeath z \u2227 Rely e3 \u2227 Mechanism z \u2227 Repair e3 \u2227 Damage z \u2227 DNA z\"\\n\\n(* Explanation 3: The loss of PALB2 in cells can lead to synthetic lethality when combined with PARP1 inhibition, as it forces cells to depend on a singular, often inadequate, DNA repair mechanism, leading to cell death. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z e1 e2 e3 e4. LossOfPALB2 x \u2227 Cells y \u2227 SyntheticLethality z \u2227 PARP1Inhibition z \u2227 Lead e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Combine e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Force e3 \u2227 Agent e3 x \u2227 Patient e3 y \u2227 Depend e4 \u2227 Agent e4 y \u2227 Mechanism z \u2227 Repair e4 \u2227 Inadequate z \u2227 CellDeath z\"\\n\\n(* Explanation 4: When cells with a loss of PALB2 rely on a singular DNA repair mechanism due to PARP1 inhibition, this can create a therapeutic window where patients may benefit from the treatment, as the inadequate repair mechanism leads to cell death. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y z w e1 e2 e3 e4 e5. Cells x \u2227 LossOfPALB2 x \u2227 Mechanism y \u2227 PARP1Inhibition z \u2227 TherapeuticWindow w \u2227 Patients y \u2227 Treatment z \u2227 Rely e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 DueTo e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Create e3 \u2227 Agent e3 x \u2227 Patient e3 w \u2227 Benefit e4 \u2227 Agent e4 y \u2227 Source e4 z \u2227 Lead e5 \u2227 Agent e5 y \u2227 Patient e5 z \u2227 CellDeath z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Patients x \u2227 LossOfPALB2 x \u2227 PARP1Inhibition y \u2227 SyntheticLethality z\"\\n  (* Hypothesis: Patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA. *)\\n  shows \"\u2203x y z e1 e2 e3. Patients x \u2227 LossOfPALB2 x \u2227 PARP1Inhibition y \u2227 SyntheticLethality z \u2227 Benefit e1 \u2227 Agent e1 x \u2227 Source e1 y \u2227 Cause e2 \u2227 Agent e2 z \u2227 Rely e3 \u2227 Agent e3 x \u2227 Mechanism z \u2227 Repair e3 \u2227 Damage z \u2227 DNA z\"\\nproof -\\n  (* From the known information, we have the conditions for patients, loss of PALB2, PARP1 inhibition, and synthetic lethality. *)\\n  from asm have \"Patients x \u2227 LossOfPALB2 x \u2227 PARP1Inhibition y \u2227 SyntheticLethality z\" <ATP>\\n  \\n  (* Explanation 3 and the logical relation Implies(And(G, I), J) allow us to infer reliance on a singular DNA repair mechanism. *)\\n  then have \"Rely e3 \u2227 Agent e3 x \u2227 Mechanism z \u2227 Repair e3 \u2227 Damage z \u2227 DNA z\" <ATP>\\n  \\n  (* Explanation 4 and the logical relation Implies(And(G, I), K) allow us to infer a therapeutic window and benefit from treatment. *)\\n  then have \"Benefit e1 \u2227 Agent e1 x \u2227 Source e1 y\" <ATP>\\n  \\n  (* We also know from explanation 2 that synthetic lethality causes cell death, which is part of the causal chain. *)\\n  then have \"Cause e2 \u2227 Agent e2 z\" <ATP>\\n  \\n  (* Combining these inferences, we can conclude the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: PARP inhibitors cause replication\u2010associated double-strand breaks (from Explanatory Sentence 1)\\nB: prevention of single-strand break repair (from Explanatory Sentence 1)\\nC: reliance on defective homologous recombination repair (from Explanatory Sentence 1)\\nD: reliance on error-prone non-homologous end joining (from Explanatory Sentence 1)\\nE: synthetic lethality occurs (from Explanatory Sentence 2)\\nF: co-occurrence of multiple genetic events (from Explanatory Sentence 2)\\nG: loss of PALB2 (from Explanatory Sentence 2)\\nH: cell death (from Explanatory Sentence 2)\\nI: PARP1 inhibition (from Explanatory Sentence 3)\\nJ: reliance on a singular DNA repair mechanism (from Explanatory Sentence 3)\\nK: therapeutic window for treatment (from Explanatory Sentence 4)\\n\\nLogical Relations:\\nImplies(B, A)\\nImplies(prevention of single-strand break repair, PARP inhibitors cause replication\u2010associated double-strand breaks)\\n--------\\nImplies(A, Or(C, D))\\nImplies(PARP inhibitors cause replication\u2010associated double-strand breaks, C | D)\\n--------\\nImplies(And(F, G), E)\\nImplies(F & G, synthetic lethality occurs)\\n--------\\nImplies(E, H)\\nImplies(synthetic lethality occurs, cell death)\\n--------\\nImplies(And(G, I), J)\\nImplies(G & I, reliance on a singular DNA repair mechanism)\\n--------\\nImplies(J, H)\\nImplies(reliance on a singular DNA repair mechanism, cell death)\\n--------\\nImplies(And(G, I), K)\\nImplies(G & I, therapeutic window for treatment)\\n--------\\n\\nDerived Implications:\\n'}",
            "9 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 7.757251501083374, 'proof tactics': ['Type unification failed: Clash of types \"entity\" and \"event\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  Cause :: event \\\\<Rightarrow> bool\\nOperand:   e2 :: entity\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_46_9\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  PARPInhibitors :: \"entity \u21d2 bool\"\\n  Breaks :: \"entity \u21d2 bool\"\\n  DoubleStrand :: \"entity \u21d2 bool\"\\n  ReplicationAssociated :: \"entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  Repair :: \"entity \u21d2 bool\"\\n  SingleStrand :: \"entity \u21d2 bool\"\\n  Break :: \"entity \u21d2 bool\"\\n  By :: \"event \u21d2 event \u21d2 bool\"\\n  Force :: \"event \u21d2 bool\"\\n  Cells :: \"entity \u21d2 bool\"\\n  Rely :: \"event \u21d2 bool\"\\n  HomologousRecombination :: \"entity \u21d2 bool\"\\n  Defective :: \"entity \u21d2 bool\"\\n  NonHomologousEndJoining :: \"entity \u21d2 bool\"\\n  ErrorProne :: \"entity \u21d2 bool\"\\n  To :: \"event \u21d2 event \u21d2 bool\"\\n  SyntheticLethality :: \"entity \u21d2 bool\"\\n  Occurs :: \"event \u21d2 bool\"\\n  CoOccurrence :: \"entity \u21d2 bool\"\\n  GeneticEvents :: \"entity \u21d2 bool\"\\n  Multiple :: \"entity \u21d2 bool\"\\n  LossOfPALB2 :: \"entity \u21d2 bool\"\\n  SuchAs :: \"entity \u21d2 entity \u21d2 bool\"\\n  Result :: \"event \u21d2 bool\"\\n  In :: \"event \u21d2 entity \u21d2 bool\"\\n  CellDeath :: \"entity \u21d2 bool\"\\n  Mechanism :: \"entity \u21d2 bool\"\\n  Singular :: \"entity \u21d2 bool\"\\n  Damage :: \"entity \u21d2 bool\"\\n  DNA :: \"entity \u21d2 bool\"\\n  Cumulative :: \"entity \u21d2 bool\"\\n  DueTo :: \"event \u21d2 event \u21d2 bool\"\\n  Inhibition :: \"entity \u21d2 bool\"\\n  PARP1 :: \"entity \u21d2 bool\"\\n  CombinedWith :: \"entity \u21d2 entity \u21d2 bool\"\\n  Lead :: \"event \u21d2 bool\"\\n  Inadequate :: \"entity \u21d2 bool\"\\n  Create :: \"event \u21d2 bool\"\\n  TherapeuticWindow :: \"entity \u21d2 bool\"\\n  Patients :: \"entity \u21d2 bool\"\\n  Benefit :: \"event \u21d2 bool\"\\n  Treatment :: \"entity \u21d2 bool\"\\n  From :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: PARP inhibitors cause replication\u2010associated double-strand breaks by preventing single-strand break repair, which forces cells to rely on defective homologous recombination repair and error-prone non-homologous end joining to repair DNA. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e1 e2 e3 e4. PARPInhibitors x \u2227 Breaks y \u2227 DoubleStrand y \u2227 ReplicationAssociated y \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Repair z \u2227 SingleStrand z \u2227 Break z \u2227 By e1 e2 \u2227 Force e3 \u2227 Cells w \u2227 Agent e3 w \u2227 Rely e4 \u2227 Agent e4 w \u2227 Repair a \u2227 HomologousRecombination a \u2227 Defective a \u2227 Repair b \u2227 NonHomologousEndJoining b \u2227 ErrorProne b \u2227 To e3 e4\"\\n\\n(* Explanation 2: Synthetic lethality occurs when the co-occurrence of multiple genetic events, such as the loss of PALB2, results in cell death due to the reliance on a singular mechanism to repair cumulative DNA damage. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2 e3 e4. SyntheticLethality x \u2227 Occurs e1 \u2227 CoOccurrence y \u2227 GeneticEvents y \u2227 Multiple y \u2227 LossOfPALB2 z \u2227 SuchAs y z \u2227 Result e2 \u2227 In e2 e3 \u2227 CellDeath e3 \u2227 Rely e4 \u2227 Mechanism a \u2227 Singular a \u2227 Repair a \u2227 Damage b \u2227 DNA b \u2227 Cumulative b \u2227 DueTo e2 e4\"\\n\\n(* Explanation 3: The loss of PALB2 in cells, when combined with PARP1 inhibition, directly leads to reliance on a singular, often inadequate, DNA repair mechanism, resulting in synthetic lethality and cell death. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z e1 e2 e3. LossOfPALB2 x \u2227 In e1 y \u2227 Cells y \u2227 Inhibition z \u2227 PARP1 z \u2227 CombinedWith x z \u2227 Lead e1 \u2227 To e1 e2 \u2227 Rely e2 \u2227 Mechanism a \u2227 Singular a \u2227 Inadequate a \u2227 Repair a \u2227 DNA b \u2227 Result e3 \u2227 SyntheticLethality c \u2227 CellDeath d \u2227 In e3 c \u2227 In e3 d\"\\n\\n(* Explanation 4: When cells with a loss of PALB2 rely on a singular DNA repair mechanism due to PARP1 inhibition, this can create a therapeutic window where patients may benefit from the treatment, as the inadequate repair mechanism leads to cell death. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y z w e1 e2 e3 e4 e5. Cells x \u2227 LossOfPALB2 y \u2227 In e1 y \u2227 Rely e1 \u2227 Agent e1 x \u2227 Mechanism z \u2227 Singular z \u2227 Repair z \u2227 DNA w \u2227 Inhibition a \u2227 PARP1 a \u2227 DueTo e1 e2 \u2227 Create e2 \u2227 TherapeuticWindow b \u2227 In e2 b \u2227 Patients c \u2227 Benefit e3 \u2227 Agent e3 c \u2227 Treatment d \u2227 From e3 d \u2227 Inadequate z \u2227 Lead e4 \u2227 To e4 e5 \u2227 CellDeath d\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Patients x \u2227 LossOfPALB2 y \u2227 Inhibition z \u2227 PARP1 z\"\\n  (* Hypothesis: Patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA. *)\\n  shows \"\u2203x y z e1 e2 e3. Patients x \u2227 LossOfPALB2 y \u2227 Inhibition z \u2227 PARP1 z \u2227 Benefit e1 \u2227 Agent e1 x \u2227 Source e1 z \u2227 SyntheticLethality e2 \u2227 Cause e2 e3 \u2227 Cells y \u2227 Rely e3 \u2227 Agent e3 y \u2227 Mechanism z \u2227 Singular z \u2227 Repair z \u2227 Damage w \u2227 DNA w \u2227 Cumulative w\"\\nproof -\\n  (* From the premise, we have known information about patients, loss of PALB2, and PARP1 inhibition. *)\\n  from asm have \"Patients x \u2227 LossOfPALB2 y \u2227 Inhibition z \u2227 PARP1 z\" <ATP>\\n  (* There is a logical relation Implies(And(G, J), K), Implies(G & J, therapeutic window is created) *)\\n  (* G is from explanatory sentence 2, J is from explanatory sentence 3, K is from explanatory sentence 4. *)\\n  (* We already have LossOfPALB2 y and PARP1 z, so we can infer that a therapeutic window is created. *)\\n  then have \"therapeutic window is created\" <ATP>\\n  (* There is a logical relation Implies(K, L), Implies(therapeutic window is created, patients benefit from treatment) *)\\n  (* K is from explanatory sentence 4, L is from explanatory sentence 4. *)\\n  (* We can infer that patients benefit from treatment. *)\\n  then have \"patients benefit from treatment\" <ATP>\\n  (* We need to show the existence of the required entities and events. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: PARP inhibitors prevent single-strand break repair (from Explanatory Sentence 1)\\nB: replication-associated double-strand breaks occur (from Explanatory Sentence 1)\\nC: cells rely on defective homologous recombination repair (from Explanatory Sentence 1)\\nD: cells rely on error-prone non-homologous end joining (from Explanatory Sentence 1)\\nE: synthetic lethality occurs (from Explanatory Sentence 2)\\nF: co-occurrence of multiple genetic events (from Explanatory Sentence 2)\\nG: loss of PALB2 (from Explanatory Sentence 2)\\nH: cell death occurs (from Explanatory Sentence 2)\\nI: reliance on a singular DNA repair mechanism (from Explanatory Sentence 3)\\nJ: PARP1 inhibition (from Explanatory Sentence 3)\\nK: therapeutic window is created (from Explanatory Sentence 4)\\nL: patients benefit from treatment (from Explanatory Sentence 4)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(PARP inhibitors prevent single-strand break repair, replication-associated double-strand breaks occur)\\n--------\\nImplies(B, Or(C, D))\\nImplies(replication-associated double-strand breaks occur, C | D)\\n--------\\nImplies(And(F, G), E)\\nImplies(F & G, synthetic lethality occurs)\\n--------\\nImplies(E, H)\\nImplies(synthetic lethality occurs, cell death occurs)\\n--------\\nImplies(And(G, J), I)\\nImplies(G & J, reliance on a singular DNA repair mechanism)\\n--------\\nImplies(I, H)\\nImplies(reliance on a singular DNA repair mechanism, cell death occurs)\\n--------\\nImplies(And(G, J), K)\\nImplies(G & J, therapeutic window is created)\\n--------\\nImplies(K, L)\\nImplies(therapeutic window is created, patients benefit from treatment)\\n--------\\n\\nDerived Implications:\\n'}",
            "10 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_46_10\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  PARPInhibitors :: \"entity \u21d2 bool\"\\n  Breaks :: \"entity \u21d2 bool\"\\n  ReplicationAssociated :: \"entity \u21d2 bool\"\\n  DoubleStrand :: \"entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  Repair :: \"entity \u21d2 bool\"\\n  SingleStrand :: \"entity \u21d2 bool\"\\n  Break :: \"entity \u21d2 bool\"\\n  Means :: \"event \u21d2 event \u21d2 bool\"\\n  Force :: \"event \u21d2 bool\"\\n  Cells :: \"entity \u21d2 bool\"\\n  Rely :: \"event \u21d2 bool\"\\n  HomologousRecombination :: \"entity \u21d2 bool\"\\n  Defective :: \"entity \u21d2 bool\"\\n  EndJoining :: \"entity \u21d2 bool\"\\n  NonHomologous :: \"entity \u21d2 bool\"\\n  ErrorProne :: \"entity \u21d2 bool\"\\n  DNA :: \"entity \u21d2 bool\"\\n  SyntheticLethality :: \"entity \u21d2 bool\"\\n  Occur :: \"event \u21d2 bool\"\\n  CoOccurrence :: \"entity \u21d2 bool\"\\n  Events :: \"entity \u21d2 bool\"\\n  Genetic :: \"entity \u21d2 bool\"\\n  Multiple :: \"entity \u21d2 bool\"\\n  Loss :: \"entity \u21d2 bool\"\\n  PALB2 :: \"entity \u21d2 bool\"\\n  SuchAs :: \"entity \u21d2 entity \u21d2 bool\"\\n  Result :: \"event \u21d2 bool\"\\n  Death :: \"entity \u21d2 bool\"\\n  Cell :: \"entity \u21d2 bool\"\\n  Mechanism :: \"entity \u21d2 bool\"\\n  Singular :: \"entity \u21d2 bool\"\\n  Damage :: \"entity \u21d2 bool\"\\n  Cumulative :: \"entity \u21d2 bool\"\\n  Reason :: \"event \u21d2 event \u21d2 bool\"\\n  InCells :: \"entity \u21d2 entity \u21d2 bool\"\\n  Inhibition :: \"entity \u21d2 bool\"\\n  PARP1 :: \"entity \u21d2 bool\"\\n  Combine :: \"event \u21d2 bool\"\\n  Lead :: \"event \u21d2 bool\"\\n  Inadequate :: \"entity \u21d2 bool\"\\n  Window :: \"entity \u21d2 bool\"\\n  Therapeutic :: \"entity \u21d2 bool\"\\n  Benefit :: \"event \u21d2 bool\"\\n  Patients :: \"entity \u21d2 bool\"\\n  Source :: \"event \u21d2 entity \u21d2 bool\"\\n  Treatment :: \"entity \u21d2 bool\"\\n  Create :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: PARP inhibitors cause replication\u2010associated double-strand breaks by preventing single-strand break repair, which forces cells to rely on defective homologous recombination repair and error-prone non-homologous end joining to repair DNA. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w v u e1 e2 e3 e4. PARPInhibitors x \u2227 Breaks y \u2227 ReplicationAssociated y \u2227 DoubleStrand y \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Repair z \u2227 SingleStrand z \u2227 Break z \u2227 Means e1 e2 \u2227 Force e3 \u2227 Agent e3 x \u2227 Patient e3 x \u2227 Rely e4 \u2227 Agent e4 x \u2227 Repair w \u2227 HomologousRecombination w \u2227 Defective w \u2227 EndJoining v \u2227 NonHomologous v \u2227 ErrorProne v \u2227 Repair w \u2227 Repair v \u2227 DNA u\"\\n\\n(* Explanation 2: Synthetic lethality occurs when the co-occurrence of multiple genetic events, such as the loss of PALB2, results in cell death due to the reliance on a singular mechanism to repair cumulative DNA damage. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z w v e1 e2 e3. SyntheticLethality x \u2227 Occur e1 \u2227 CoOccurrence y \u2227 Events y \u2227 Genetic y \u2227 Multiple y \u2227 Loss z \u2227 PALB2 z \u2227 SuchAs y z \u2227 Result e2 \u2227 Agent e2 y \u2227 Patient e2 z \u2227 Cell z \u2227 Rely e3 \u2227 Mechanism w \u2227 Singular w \u2227 Repair w \u2227 Damage v \u2227 Cumulative v \u2227 DNA v \u2227 Reason e2 e3\"\\n\\n(* Explanation 3: The loss of PALB2 in cells, when combined with PARP1 inhibition, directly leads to reliance on a singular, often inadequate, DNA repair mechanism, resulting in synthetic lethality and cell death. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z e1 e2 e3. Loss x \u2227 PALB2 x \u2227 InCells x y \u2227 Inhibition y \u2227 PARP1 y \u2227 Combine e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Lead e2 \u2227 Agent e2 x \u2227 Rely e3 \u2227 Mechanism z \u2227 Singular z \u2227 Inadequate z \u2227 Repair z \u2227 Result e2 \u2227 SyntheticLethality x \u2227 Result e2 \u2227 Death x \u2227 Cell x\"\\n\\n(* Explanation 4: When cells with a loss of PALB2 rely on a singular DNA repair mechanism due to PARP1 inhibition, this can create a therapeutic window where patients may benefit from the treatment, as the inadequate repair mechanism leads to cell death. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y z w v u e1 e2 e3 e4 e5. Cells x \u2227 Loss y \u2227 PALB2 y \u2227 InCells y x \u2227 Rely e1 \u2227 Agent e1 x \u2227 Mechanism z \u2227 Singular z \u2227 Repair z \u2227 Inhibition w \u2227 PARP1 w \u2227 Reason e1 e2 \u2227 Create e2 \u2227 Agent e2 x \u2227 Window e3 \u2227 Therapeutic e3 \u2227 Patient e2 e3 \u2227 Benefit e4 \u2227 Patients v \u2227 Agent e4 v \u2227 Treatment u \u2227 Source e4 u \u2227 Lead e5 \u2227 Agent e5 z \u2227 Patient e5 x \u2227 Cell x \u2227 Inadequate z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Patients x \u2227 Loss y \u2227 Inhibition z \u2227 PARP1 z\"\\n  (* Hypothesis: Patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA. *)\\n  shows \"\u2203x y z w v e1 e2 e3. Patients x \u2227 Loss y \u2227 Inhibition z \u2227 PARP1 z \u2227 Benefit e1 \u2227 Agent e1 x \u2227 Source e1 z \u2227 SyntheticLethality e2 \u2227 Cause e2 e3 \u2227 Rely e3 \u2227 Agent e3 x \u2227 Mechanism w \u2227 Singular w \u2227 Repair w \u2227 Damage v \u2227 Cumulative v \u2227 DNA v\"\\nproof -\\n  (* From the premise, we have known information about patients, loss, inhibition, and PARP1. *)\\n  from asm have \"Patients x \u2227 Loss y \u2227 Inhibition z \u2227 PARP1 z\" <ATP>\\n  (* Explanation 3 and Explanation 4 are relevant to the hypothesis. *)\\n  (* Explanation 3: The loss of PALB2 in cells, when combined with PARP1 inhibition, directly leads to reliance on a singular, often inadequate, DNA repair mechanism, resulting in synthetic lethality and cell death. *)\\n  (* Explanation 4: When cells with a loss of PALB2 rely on a singular DNA repair mechanism due to PARP1 inhibition, this can create a therapeutic window where patients may benefit from the treatment, as the inadequate repair mechanism leads to cell death. *)\\n  (* Logical relation: Implies(And(G, H), K) *)\\n  (* We can infer the therapeutic window where patients may benefit from the treatment. *)\\n  then have \"therapeutic window where patients may benefit from the treatment\" <ATP>\\n  (* Explanation 2: Synthetic lethality occurs when the co-occurrence of multiple genetic events, such as the loss of PALB2, results in cell death due to the reliance on a singular mechanism to repair cumulative DNA damage. *)\\n  (* Logical relation: Implies(And(E, F), D) *)\\n  (* We can infer synthetic lethality occurs. *)\\n  then have \"synthetic lethality occurs\" <ATP>\\n  (* Combine the results to show the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: PARP inhibitors cause replication\u2010associated double-strand breaks (from Explanatory Sentence 1)\\nB: prevention of single-strand break repair (from Explanatory Sentence 1)\\nC: reliance on defective homologous recombination repair and error-prone non-homologous end joining (from Explanatory Sentence 1)\\nD: synthetic lethality occurs (from Explanatory Sentence 2)\\nE: co-occurrence of multiple genetic events, such as the loss of PALB2 (from Explanatory Sentence 2)\\nF: reliance on a singular mechanism to repair cumulative DNA damage (from Explanatory Sentence 2)\\nG: loss of PALB2 in cells (from Explanatory Sentence 3)\\nH: PARP1 inhibition (from Explanatory Sentence 3)\\nI: reliance on a singular, often inadequate, DNA repair mechanism (from Explanatory Sentence 3)\\nJ: cell death (from Explanatory Sentence 3)\\nK: therapeutic window where patients may benefit from the treatment (from Explanatory Sentence 4)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(PARP inhibitors cause replication\u2010associated double-strand breaks, prevention of single-strand break repair)\\n--------\\nImplies(B, C)\\nImplies(prevention of single-strand break repair, reliance on defective homologous recombination repair and error-prone non-homologous end joining)\\n--------\\nImplies(And(E, F), D)\\nImplies(E & F, synthetic lethality occurs)\\n--------\\nImplies(And(G, H), I)\\nImplies(G & H, reliance on a singular, often inadequate, DNA repair mechanism)\\n--------\\nImplies(I, J)\\nImplies(reliance on a singular, often inadequate, DNA repair mechanism, cell death)\\n--------\\nImplies(And(G, H), K)\\nImplies(G & H, therapeutic window where patients may benefit from the treatment)\\n--------\\n\\nDerived Implications:\\nImplies(A, C)\\nImplies(PARP inhibitors cause replication\u2010associated double-strand breaks, reliance on defective homologous recombination repair and error-prone non-homologous end joining)\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(reliance on defective homologous recombination repair and error-prone non-homologous end joining), Not(PARP inhibitors cause replication\u2010associated double-strand breaks))\\n--------\\n'}"
        ]
    }
}